empower pharmacy lawsuit semaglutide update Ozempic [July 2026 Update] Empower GLP-1 Lawsuit Update: Legal
Description
Liver transaminases were significantly reduced after 12 months of PIO therapy, as well as after combination therapy
2025 Mar;13(3):e6
![empower pharmacy lawsuit semaglutide update Ozempic [July 2026 Update] Empower GLP-1 Lawsuit Update: Legal](https://i.abcnewsfe.com/a/060df6de-2ed3-4bc4-947c-d08e1b3f2de2/wegovy-file-gty-ml-241023_1729699736166_hpMain.jpg)
Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone your gut produces after eating
Proper fluid intake eliminates this risk entirely
However, this risk diminished over time
![empower pharmacy lawsuit semaglutide update Ozempic [July 2026 Update] Empower GLP-1 Lawsuit Update: Legal](https://njbiz.com/files/2024/11/Ozempic-semaglutide-injection.jpg)
May 2026 Savings - use promotion code